Bulletin
Investor Alert

International Flavors & Fragrances Inc.

NYS: IFF

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
International Flavors & Fragrances Inc.

After Hours

 --Quotes are delayed by 20 min

Jun 24, 2022, 4:26 p.m.

IFF
/zigman2/quotes/206698429/composite

$

121.41

Change

0.00 0.00%

Volume

Volume 94,730

Quotes are delayed by 20 min

/zigman2/quotes/206698429/composite

Previous close

$ 116.37

$ 121.41

Change

+5.04 +4.33%

Day low

Day high

$117.13

$121.46

Open

52 week low

52 week high

$105.38

$157.08

Open

Company Description

International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish se...

International Flavors & Fragrances, Inc. engages in the manufacture and supply of flavors and fragrances used in the food, beverage, personal care, and household products industries. It operates through the following segments: Nourish, Health & Biosciences, Scent and Pharma Solutions. The Nourish segment consists of legacy Taste segment combined with N&B's Food & Beverage division and the food protection business of N&B's Health & Biosciences division. The Health & Biosciences business consists of a biotechnology-driven portfolio of enzymes, food cultures, probiotics and specialty ingredients for food, home and personal care, and health and wellness applications. The Scent business creates fragrance compounds, fragrance ingredients and cosmetic ingredients that are integral elements in the world’s finest perfumes and best-known household and personal care products. The Pharma Solutions business produces a vast portfolio including cellulosics and seaweed-based pharma excipients, used to improve the functionality and delivery of active pharmaceutical ingredients, including controlled or modified drug release formulations, and enabling. The company was founded in 1833 and is headquartered in New York, NY.

Valuation

P/E Current

105.51

P/E Ratio (with extraordinary items)

53.47

P/E Ratio (without extraordinary items)

136.59

Price to Sales Ratio

3.14

Price to Book Ratio

1.82

Price to Cash Flow Ratio

25.48

Enterprise Value to EBITDA

20.09

Enterprise Value to Sales

3.31

Efficiency

Total Asset Turnover

0.44

Liquidity

Current Ratio

1.92

Quick Ratio

1.23

Cash Ratio

0.20

Profitability

Gross Margin

25.75

Operating Margin

7.65

Pretax Margin

3.04

Net Margin

2.30

Return on Assets

1.01

Return on Equity

1.96

Return on Total Capital

4.00

Capital Structure

Total Debt to Total Assets

30.76

Officers and Executives

Name Age Officer Since Title
Mr. Franklin K. Clyburn 56 2022 Chief Executive Officer & Director
Mr. Francisco Fortanet 50 1995 Executive Vice President-Operations
Mr. Glenn Robert Richter 59 2021 Chief Financial Officer & Executive Vice President
Mr. Vic Verma 53 2016 Chief Information Officer & Senior Vice President
Dr. Gregory Yep 54 2016 Chief Global Scientific & Sustainability Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
06/01/2022 Christophe de Villeplee
President, Scent 		629   Disposition at $132.59 per share. 83,399
05/05/2022 Christina A. Gold
Director 		1,089   Derivative/Non-derivative trans. at $0 per share. 0
05/05/2022 Ilene S. Gordon
Director 		1,089   Derivative/Non-derivative trans. at $0 per share. 0
05/05/2022 Edward D. Breen
Director 		1,089   Derivative/Non-derivative trans. at $0 per share. 0
05/05/2022 Kåre Schultz
Director 		1,089   Derivative/Non-derivative trans. at $0 per share. 0
05/05/2022 Matthias J. Heinzel
Director 		1,089   Derivative/Non-derivative trans. at $0 per share. 0
05/05/2022 Barry A. Bruno
Director 		289   Derivative/Non-derivative trans. at $0 per share. 0
05/02/2022 Christophe de Villeplee
President, Scent 		630   Disposition at $121.68 per share. 76,658
04/01/2022 Nicolas Mirzayantz
President, Nourish 		2,042   Derivative/Non-derivative trans. at $134.33 per share. 274,301
04/01/2022 Francisco Fortanet
EVP, Operations 		1,912   Derivative/Non-derivative trans. at $134.33 per share. 256,838
04/01/2022 Robert G. Anderson
Controller 		625   Derivative/Non-derivative trans. at $134.33 per share. 83,956
04/01/2022 Christophe de Villeplee
President, Scent 		256   34,388
04/01/2022 Nicolas Mirzayantz
President, Nourish 		4,353   Derivative/Non-derivative trans. at $0 per share. 0
04/01/2022 Francisco Fortanet
EVP, Operations 		5,006   Derivative/Non-derivative trans. at $0 per share. 0
04/01/2022 Robert G. Anderson
Controller 		1,741   Derivative/Non-derivative trans. at $0 per share. 0
04/01/2022 Christophe de Villeplee
President, Scent 		285   Derivative/Non-derivative trans. at $118.1 per share. 33,658
04/01/2022 Christophe de Villeplee
President, Scent 		2,176   Derivative/Non-derivative trans. at $0 per share. 0
03/15/2022 Robert G. Anderson
Controller 		288   Derivative/Non-derivative trans. at $120.48 per share. 34,698
03/15/2022 Robert G. Anderson
Controller 		662   Award at $0 per share. 0
02/19/2022 Simon W. Herriott
President Health & Biosciences 		155   Derivative/Non-derivative trans. at $135.03 per share. 20,929
02/19/2022 Angela Strzelecki
President, Pharma Solutions 		188   Derivative/Non-derivative trans. at $135.03 per share. 25,385
02/19/2022 Jennifer Johnson
EVP, General Counsel 		273   Derivative/Non-derivative trans. at $135.03 per share. 36,863
02/19/2022 Simon W. Herriott
President Health & Biosciences 		616   Derivative/Non-derivative trans. at $0 per share. 0
02/19/2022 Angela Strzelecki
President, Pharma Solutions 		585   Derivative/Non-derivative trans. at $0 per share. 0
02/19/2022 Jennifer Johnson
EVP, General Counsel 		708   Derivative/Non-derivative trans. at $0 per share. 0
02/14/2022 Simon W. Herriott
President Health & Biosciences 		132   Derivative/Non-derivative trans. at $132.1 per share. 17,437
02/14/2022 Angela Strzelecki
President, Pharma Solutions 		120   Derivative/Non-derivative trans. at $132.1 per share. 15,852
02/14/2022 Jennifer Johnson
EVP, General Counsel 		152   Derivative/Non-derivative trans. at $132.1 per share. 20,079
02/14/2022 Simon W. Herriott
President Health & Biosciences 		525   Derivative/Non-derivative trans. at $0 per share. 0
02/14/2022 Angela Strzelecki
President, Pharma Solutions 		366   Derivative/Non-derivative trans. at $0 per share. 0
02/14/2022 Jennifer Johnson
EVP, General Counsel 		366   Derivative/Non-derivative trans. at $0 per share. 0
01/02/2022 Christophe de Villeplee
President, Scent 		784   Derivative/Non-derivative trans. at $149.12 per share. 116,910
12/31/2021 Simon W. Herriott
President Health & Biosciences 		891   Derivative/Non-derivative trans. at $149.82 per share. 133,489
12/31/2021 Jennifer Johnson
EVP, General Counsel 		1,236   Derivative/Non-derivative trans. at $149.82 per share. 185,177
12/31/2021 Simon W. Herriott
President Health & Biosciences 		3,241   Derivative/Non-derivative trans. at $0 per share. 0
12/31/2021 Jennifer Johnson
EVP, General Counsel 		3,241   Derivative/Non-derivative trans. at $0 per share. 0
12/30/2021 Angela Strzelecki
President, Pharma Solutions 		3,481   Derivative/Non-derivative trans. at $115.48 per share. 401,985
/news/latest/company/us/iff

MarketWatch News on IFF

  21. Loading more headlines...
/news/nonmarketwatch/company/us/iff

Other News on IFF

  3. DuPont, Eastman among five chemical companies cut at Jefferies

    12:36 p.m. June 16, 2022

    - Seeking Alpha

  5. Tracking Carl Icahn's Portfolio - Q1 2022 Update

    3:42 a.m. June 13, 2022

    - Seeking Alpha

  10. How Much the Biggest U.S. Companies Pay Workers

    10:19 p.m. May 31, 2022

    - John Stensholt

  11. Wide-Moat Stocks On Sale - The June 2022 Heat Map

    3:20 a.m. May 31, 2022

    - Seeking Alpha

  12. Gates Capital Management, Inc. Buys 2, Sells 3 in 1st Quarter

    1:00 p.m. May 18, 2022

    - GuruFocus.com

  13. International Flavors & Fragrances Serves Up Value

    9:51 a.m. May 18, 2022

    - GuruFocus.com

  14. Top 5 1st Quarter Trades of Sachem Head Capital Management LP

    7:00 p.m. May 15, 2022

    - GuruFocus.com

  15. Wall Street Breakfast: What Moved Markets

    7:52 a.m. May 14, 2022

    - Seeking Alpha

  16. Top 5 1st Quarter Trades of Searle & Co.

    7:00 p.m. May 10, 2022

    - GuruFocus.com

  19. 10-Q: INTERNATIONAL FLAVORS & FRAGRANCES INC

    5:04 p.m. May 9, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  20. International Flavors & Fragrances Q1 2022 Earnings Preview

    5:35 p.m. May 8, 2022

    - Seeking Alpha

  21. Loading more headlines...

At a Glance

International Flavors & Fragrances, Inc.

521 West 57th Street

New York, New York 10019-2960

Phone

1 2127655500

Industry

Chemicals

Sector

Basic Materials/Resources

Fiscal Year-end

12/2022

View SEC Filings

Revenue

$11.66B

Net Income

$268.00M

Employees

24,000

Annual Report for IFF

/news/pressrelease/company/us/iff

Press Releases on IFF

  1. International Flavors IFF Investment Analysis

    9:03 a.m. June 17, 2022

    - Stock Traders Daily

  3. When International Flavors (IFF) Moves Investors should Listen

    8:44 a.m. June 6, 2022

    - Stock Traders Daily

  5. International Flavors (IFF) Trading Report

    12:32 p.m. May 27, 2022

    - Stock Traders Daily

  7. International Flavors IFF Investment Analysis and Advice

    5:48 p.m. May 17, 2022

    - Stock Traders Daily

  8. IFF Reports First Quarter 2022 Results

    4:15 p.m. May 9, 2022

    - BusinessWire - BZX

  9. International Flavors (IFF) Trading Report

    12:25 a.m. May 8, 2022

    - Stock Traders Daily

  10. IFF Declares Dividend for Second Quarter 2022

    4:15 p.m. May 5, 2022

    - BusinessWire - BZX

  15. International Flavors IFF Trading Report

    8:18 a.m. April 28, 2022

    - Stock Traders Daily

  16. IFF to Release First Quarter 2022 Results May 9

    5:22 p.m. April 26, 2022

    - BusinessWire - BZX

  17. International Flavors IFF Trading Signals

    3:30 p.m. April 18, 2022

    - Stock Traders Daily

  19. International Flavors IFF Trading Report

    9:43 p.m. April 8, 2022

    - Stock Traders Daily

  20. IFF Completes Acquisition of Health Wright Products

    4:15 p.m. April 4, 2022

    - BusinessWire - BZX

  21. Loading more headlines...
Link to MarketWatch's Slice.